AUPO573697A0 - Diagnosis of endometrial cancer - Google Patents

Diagnosis of endometrial cancer

Info

Publication number
AUPO573697A0
AUPO573697A0 AUPO5736A AUPO573697A AUPO573697A0 AU PO573697 A0 AUPO573697 A0 AU PO573697A0 AU PO5736 A AUPO5736 A AU PO5736A AU PO573697 A AUPO573697 A AU PO573697A AU PO573697 A0 AUPO573697 A0 AU PO573697A0
Authority
AU
Australia
Prior art keywords
endometrial cancer
diagnosis
matrix metalloproteinase
assaying
qualitative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO5736A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Prince Henrys Institute of Medical Research
Original Assignee
University of Melbourne
Prince Henrys Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne, Prince Henrys Institute of Medical Research filed Critical University of Melbourne
Priority to AUPO5736A priority Critical patent/AUPO573697A0/en
Publication of AUPO573697A0 publication Critical patent/AUPO573697A0/en
Priority to PCT/AU1998/000189 priority patent/WO1998042865A1/en
Priority to US09/381,454 priority patent/US6607894B1/en
Priority to EP98909221A priority patent/EP0979304B1/en
Priority to ES98909221T priority patent/ES2268767T3/es
Priority to MYPI98001218A priority patent/MY119567A/en
Priority to NZ337868A priority patent/NZ337868A/en
Priority to JP54453698A priority patent/JP4183757B2/ja
Priority to DE69835010T priority patent/DE69835010T2/de
Priority to AU63859/98A priority patent/AU728286B2/en
Priority to CA2284099A priority patent/CA2284099C/en
Priority to CN98805312A priority patent/CN1257550A/zh
Priority to KR1019997009429A priority patent/KR20010006344A/ko
Priority to ZA982403A priority patent/ZA982403B/xx
Priority to AT98909221T priority patent/ATE331039T1/de
Priority to JP2007001867A priority patent/JP2007202556A/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
AUPO5736A 1997-03-20 1997-03-20 Diagnosis of endometrial cancer Abandoned AUPO573697A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer
AT98909221T ATE331039T1 (de) 1997-03-20 1998-03-20 Feststellung von endometriumkrebs
NZ337868A NZ337868A (en) 1997-03-20 1998-03-20 Detection of endometrial cancer using a matrix metalloprotease
DE69835010T DE69835010T2 (de) 1997-03-20 1998-03-20 Feststellung von endometriumkrebs
EP98909221A EP0979304B1 (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
ES98909221T ES2268767T3 (es) 1997-03-20 1998-03-20 Deteccion de cancer de endometrio.
MYPI98001218A MY119567A (en) 1997-03-20 1998-03-20 Matrix metalloproteinase levels as indicators of endometrial cancer
PCT/AU1998/000189 WO1998042865A1 (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
JP54453698A JP4183757B2 (ja) 1997-03-20 1998-03-20 子宮内膜ガンの検出
US09/381,454 US6607894B1 (en) 1997-03-20 1998-03-20 Matrix metalloproteinase levels as indicators of endometrial cancer
AU63859/98A AU728286B2 (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
CA2284099A CA2284099C (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
CN98805312A CN1257550A (zh) 1997-03-20 1998-03-20 子宫内膜癌的检测
KR1019997009429A KR20010006344A (ko) 1997-03-20 1998-03-20 자궁내막암의 검출 방법
ZA982403A ZA982403B (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
JP2007001867A JP2007202556A (ja) 1997-03-20 2007-01-09 子宮内膜ガンの検出

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer

Publications (1)

Publication Number Publication Date
AUPO573697A0 true AUPO573697A0 (en) 1997-04-10

Family

ID=3800039

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO5736A Abandoned AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer

Country Status (14)

Country Link
US (1) US6607894B1 (enExample)
EP (1) EP0979304B1 (enExample)
JP (2) JP4183757B2 (enExample)
KR (1) KR20010006344A (enExample)
CN (1) CN1257550A (enExample)
AT (1) ATE331039T1 (enExample)
AU (1) AUPO573697A0 (enExample)
CA (1) CA2284099C (enExample)
DE (1) DE69835010T2 (enExample)
ES (1) ES2268767T3 (enExample)
MY (1) MY119567A (enExample)
NZ (1) NZ337868A (enExample)
WO (1) WO1998042865A1 (enExample)
ZA (1) ZA982403B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322023A1 (en) * 1998-03-05 1999-09-10 John D. Burczak A novel method of detecting and monitoring endometrial and uterine cancers
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
DE10217677A1 (de) 2002-04-19 2003-11-06 Bayer Ag Verwendung von Aufhellern zur Herstellung von Streichmassen
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
ATE463743T1 (de) * 2004-07-23 2010-04-15 Ct De Rech Public De La Sante Überwachung von herzversagen
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
US20060177448A1 (en) * 2005-02-09 2006-08-10 Genentech, Inc. Inhibiting HER2 shedding with matrix metalloprotease antagonists
WO2007086915A2 (en) * 2005-05-12 2007-08-02 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
RU2304782C1 (ru) * 2005-12-28 2007-08-20 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ прогнозирования рецидива эндометриоидной кисты яичника
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
WO2009059284A2 (en) 2007-11-02 2009-05-07 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US20120183976A1 (en) * 2009-04-16 2012-07-19 He Zhou Methods of assessing activity of a polysaccharide composition
DK2456889T3 (en) 2009-07-24 2014-12-01 Geadic Biotec Aie Markers of endometrial cancer
JP5982361B2 (ja) 2010-04-16 2016-08-31 モメンタ ファーマシューティカルズ インコーポレイテッド 組織標的化方法
RU2430371C1 (ru) * 2010-04-26 2011-09-27 Учреждение Российской академии наук Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) Способ дифференциальной диагностики и прогноза миомы и рака эндометрия
CA2795868A1 (en) 2010-06-17 2011-12-22 Momenta Pharmaceuticals, Inc. Methods and compositions for modulating hair growth
AU2012261953A1 (en) * 2011-06-03 2013-12-12 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
WO2013044187A2 (en) * 2011-09-22 2013-03-28 Memorial Sloan-Kettering Cancer Center Detecting ovarian cancer
PL2809801T3 (pl) * 2012-01-31 2018-12-31 SPEISER, Paul Nieinwazyjna diagnoza raka
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
WO2016000028A1 (en) * 2014-07-02 2016-01-07 Bionomics Limited Predictive biomarkers
WO2016127067A1 (en) * 2015-02-06 2016-08-11 Quest Diagnostics Investments Incorporated Compositions and methods for determining endometrial cancer prognosis
CA3286798A1 (en) * 2016-05-04 2025-10-30 Fundacio Hospital Universitari Vall D'hebron-Institut De Recerca Markers of endometrial cancer
IN202021002695A (enExample) 2020-01-21 2021-07-23
CN112961921B (zh) * 2021-03-26 2022-07-01 中国医学科学院北京协和医院 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5324634A (en) 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1994005807A1 (en) * 1992-08-28 1994-03-17 Dickson Robert B Matrix-degrading metalloproteinase
EP0674710B1 (en) * 1992-11-16 2003-05-02 Cancer Research Fund Of Contra Costa Peptides with broad neoplastic specificity

Also Published As

Publication number Publication date
CA2284099C (en) 2010-04-27
CN1257550A (zh) 2000-06-21
EP0979304A1 (en) 2000-02-16
EP0979304A4 (en) 2003-06-11
ZA982403B (en) 1998-10-21
US6607894B1 (en) 2003-08-19
EP0979304B1 (en) 2006-06-21
ES2268767T3 (es) 2007-03-16
ATE331039T1 (de) 2006-07-15
JP2007202556A (ja) 2007-08-16
WO1998042865A1 (en) 1998-10-01
JP2002501613A (ja) 2002-01-15
DE69835010D1 (de) 2006-08-03
KR20010006344A (ko) 2001-01-26
NZ337868A (en) 2002-05-31
DE69835010T2 (de) 2007-06-06
CA2284099A1 (en) 1998-10-01
MY119567A (en) 2005-06-30
JP4183757B2 (ja) 2008-11-19

Similar Documents

Publication Publication Date Title
AUPO573697A0 (en) Diagnosis of endometrial cancer
AU4085097A (en) Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
HK1040533A1 (zh) 监察蛋白脢体抑制剂药物活动的方法
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
IL114564A (en) Method for the sensitive detection of nucleic acids
GB2202328B (en) Method for assaying nucleic acids, reagent combination and kit therefor
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
AU2144000A (en) Complexity management and analysis of genomic dna
ES8609472A1 (es) Una sonda de deteccion de acidos nucleicos
DE69931910D1 (en) Pränatales screening für downs-syndrom
ATE224456T1 (de) Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft
ATE107705T1 (de) Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten.
AU2304697A (en) Diagnostic method and apparatus
AU2904197A (en) Diagnostic method and apparatus based on polymorphism in an IL-6 gene
AU5218599A (en) Method and system for identifying at risk patients diagnosed with diabetes
WO1999054707A3 (en) Fetal testing for prediction of low birth weight
FI990380A7 (fi) Diagnostinen ja seulontamenetelmä
AU6189486A (en) Monoclonal antibodies to prosomal proteins
BR0007056A (pt) Enzima mutante produtora de nucleosìdeo-5' -fosfato, métodos para a produção de uma enzima mutante produtora de nucleosìdeo-5' -fosfato, de um inibidor para uma enzima fosfatase ou de transfosforilação e de um nucleosìdeo-5' -fosfato, cristais de uma enzima, de fosfatase ácida e de complexo de fosfatase ácida, gene, dna recombinante, e, microorganismo
WO2001077380A3 (en) Method for predicting predisposition to a disease associated with mutations in a rpgr gene
AU4407285A (en) Methods and apparatus for carrying out clinical, chemical and biological testing
AU4857796A (en) Sex-specific dna probe for parrots, methods and kits
AU5801196A (en) Relaxin diagnostic assays and kits, and methods and uses thereof
UA20025A (uk) Спосіб прогhозуваhhя затримки розвитку плода
HK1021649A (en) Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer